Building Your Knowledge of Vascular Parkinsonism

Vascular parkinsonism (VaP) is a condition where symptoms similar to Parkinson’s disease—such as slowness, stiffness, and balance issues—are caused by blood vessel damage in the brain rather than the typical loss of brain cells seen in idiopathic Parkinson’s disease ^[1][2]. While idiopathic Parkinson’s (Parkinson’s disease with no single identified cause) is a neurodegenerative disease (a slow breakdown of specific neurons), VaP is a consequence of cerebrovascular disease, such as strokes or chronic “silent” injury to small blood vessels ^[3].

Because it is often confused with other movement disorders, VaP is frequently under-recognized. Published summaries estimate that it accounts for anywhere from 1% to 15% of all parkinsonism cases ^[4]. This broad range depends heavily on the population studied, but it highlights that the condition is relatively common among older adults with vascular risk factors like high blood pressure or diabetes ^[2].

Two Ways the Condition Begins

Doctors generally recognize two main patterns of how VaP develops, depending on the type of vascular injury involved.

Insidious-Onset (Small Vessel Disease)

This is the most common form of VaP. It develops gradually over months or years due to cerebral small vessel disease—the chronic narrowing and blockage of tiny arteries deep in the brain ^[1].

• Symptoms: This typically presents as “lower-body parkinsonism,” where walking and balance are much more affected than arm movement ^[5].
• Response: These symptoms often do not respond well to traditional Parkinson’s medications like levodopa ^[2].

Acute or Subacute (Post-Stroke)

This form occurs suddenly or shortly after a documented stroke. It happens when an infarct (an area of dead tissue caused by lack of blood flow) occurs in a “strategic” location, such as the parts of the brain that control movement (the basal ganglia) or the pathways that transport dopamine ^[1][2].

• Symptoms: Unlike the gradual form, this often starts on just one side of the body ^[5].
• Response: Because it directly impacts the dopamine-producing pathways, this subtype may actually show a good response to levodopa therapy ^[1].

How Vascular Damage Affects Movement

In idiopathic Parkinson’s disease, the primary problem is the loss of dopamine-producing cells in a specific area called the substantia nigra ^[3]. In VaP, the biological mechanism is different.

Ischemic injury (damage from lack of oxygen) disrupts the frontosubcortical motor networks—the “wiring” that connects the front of the brain to the deep movement centers ^[2]. When these circuits are damaged by small strokes or chronic white-matter injury, the brain can no longer coordinate movement effectively. This disruption often affects the pathways responsible for walking and upright posture more severely than those responsible for fine hand movements, which is why “lower-body” symptoms are so prominent ^[6].

Distinguishing Vascular Parkinsonism from Parkinson’s Disease

While they share a name, VaP and idiopathic Parkinson’s disease (PD) have distinct clinical and structural characteristics. These are general tendencies rather than absolute rules:

The Reality of “Mixed” Parkinsonism

It is important to understand that these two conditions are not always mutually exclusive. In fact, many people have mixed parkinsonism, where they have both the neurodegenerative changes of PD and the vascular damage of VaP ^[1]. Studies of brain tissue often show that older adults may have both Lewy bodies (the hallmark of PD) and evidence of multiple small strokes ^[3]. In these cases, the vascular damage can make PD symptoms appear earlier or progress more quickly than they otherwise would.

The Role of Imaging in Diagnosis

Your doctor may use several types of imaging to help differentiate these conditions, but it is important to know that neither test alone determines the diagnosis:

• MRI: Used to look for lacunes (tiny holes left by old strokes) or white-matter hyperintensities (areas that appear bright on scans, indicating damage to the brain’s “wiring”) ^[7][9].
• DaTscan: A specialized scan that measures dopamine-transporter availability in the striatum. While often normal in pure VaP, it can be abnormal in PD, atypical parkinsonism, or if a stroke hit a strategic location ^[8][10]. An abnormal result is not specific to idiopathic PD.
• Nigrosome-1 MRI: A technique that looks for a specific “swallow-tail” pattern in the brain. While its absence may support neurodegeneration, it is not a universally available or definitively disease-specific test ^[11][12].

Ultimately, the diagnosis of VaP is based on the whole clinical picture: how your symptoms started, what they look like today, and what the imaging shows about your brain’s vascular health ^[1].